CMP Pharma develops, manufactures and commercializes specialty pharmaceuticals, focused on niche oral liquid, injectable and topical products that solve unmet patient needs. CaroSpir®(Spironolactone Oral Suspension, 25 mg/5mL) is the first and only FDA-approved oral Suspension of the potassium-sparing diuretic spironolactone.